DCF ScreenerData as of Oct 10, 2026, 1:06 AM UTC
← Screener

MRK Merck & Co., Inc.

Healthcare

Price
$141.94
Intrinsic value
$41.77
Buy price
$33.41
Discount
-239.8%
Overvalued [LOW CF reliability]

Live signals (1)

Daily bars as of Oct 8, 2026
  • UCUptrend ContinuationBullish ↑

    A strong bullish bar closing back into a rising 20/50-SMA stack - the uptrend resuming after a pullback to the moving averages.

    Fired Oct 8, 2026on the latest daily bar35.8% win rate · 1x profit factor

A pattern is reported for 5 bars after it fires (the sweet-spot fill window), so an older bar count means the entry has had longer to play out - not that the signal is stronger. Win rate and profit factor are the pattern's backtested averages across the S&P 500, not a forecast for this ticker.

DCF walkthrough

Near-term growth (g1)3.12%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
Operating CF
$19,967,000,000.00
Total debt
$53,910,999,040.00
Cash & STI
$7,141,000,192.00
Shares out.
2,470,000,000
Overvalued [LOW CF reliability]
Intrinsic value$41.77
Buy price (with MOS)$33.41
Current price$141.94
Discount to intrinsic value-239.8%

7-step quality scorecard

ROE quality
HIGH_VOLATILE
Average ROE
26.0%
Current ROE
34.7%
Minimum ROE
1.0%
Debt quality
LEVERAGED
Debt / Equity
1.02x
Moat proxy
MODERATE_PROXY
Cash-flow reliability
LOW
Operating CF / Net income
6.29x

Technical chart

Confluence: WEAK (1/3)

Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim (see Live signals above for when it fired).

Assumptions & data quality

Data source
yfinance
Growth (g1) source
revenueCAGR
Valuation model
DCF_OCF
Debt as % of DCF PV
35.9%
Public economic interest
99.9%

These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.